COVID-19 Vaccines Lower Risk of Heart Attack and Cardiac Death

ccording to three different studies, COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events (MACE), in addition to other outcomes, particularly among older adults.

Shingles Vaccine Reduces Risk of a Dementia Diagnosis

According to a cohort study using target trial emulation, older adults at higher risk for dementia are less likely to have a dementia diagnosis if they received a herpes zoster (shingles) vaccine.

Study Finds Flu Vaccine Sharply Reduces Infections in Children Ages 2 to 5

A study has found pediatric flu vaccines significantly reduce the number of childhood cases of influenza.

Cancer Vaccine Produces 49 Percent Melanoma Reduction in Patients

A study has found the combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, is successful in cutting the risk of skin cancer recurrence and death by 49 percent.

Study Finds Moderna and Pfizer/BioNTech COVID-19 Vaccines 70 to 76 Percent Effective Against Severe Illness in Kids

A recent study in Taiwan that examined the vaccine effectiveness (VE) against moderate to severe COVID-19 infection in children aged 6 to 11 years found the Pfizer/BioNTech BNT162b2 VE was 69.9 percent and the Moderna mRNA-1273 VE was 75.5 percent during Omicron BA.2/BA.5 predominance in 2022.

Reduced Risk of Dementia Linked to Eight Vaccines

According to multiple large observational studies, the risk of dementia is associated with eight routine adult vaccines: the shingles, respiratory syncytial virus, influenza, DTP (diphtheria, tetanus and pertussis), pneumococcal, hepatitis A, hepatitis B and typhoid vaccines.

Novel Flu Vaccine Offers Broad Protection Against Multiple Flu Viruses

A potentially effective mucosal vaccine platform has been developed to encourage broad, protective immunity against multiple influenza virus infections.

Flu Vaccine Even with Infection Reduces Risk of Heart and Stroke

A new study shows that influenza vaccination may help protect against heart attack and stroke even when it does not prevent people from getting the flu.

High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s

Researchers have found that adults 65 and older who received a high-dose influenza vaccine had a significantly lower risk of developing Alzheimer’s disease compared to those who received the standard dose.

AREXVY RSV Vaccine Approved for Expanded Age Indication

The U.S. Food and Drug Administration has expanded the approved age indication of AREXVY to adults aged 18 to 49 years at increased risk for lower respiratory tract disease caused by RSV.